# FDA recall D-0297-2021

> **Teva Pharmaceuticals USA** · Class II · drug recall initiated 2021-02-15.

## Product

Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 25x2mL Single Dose Vials, Rx only, Distributed by Teva Pharmaceuticals, USA, Inc., Parsippany, NJ Vial NDC 0703-4502-01 (vial) NDC# 0703-4502-04 (tray)

## Reason for recall

Chemical contamination; Unknown brown residue adhering to the inside of one vial.

## Distribution

Nationwide, including Puerto Rico

## Key facts

- **Recall number:** D-0297-2021
- **Recalling firm:** Teva Pharmaceuticals USA
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2021-02-15
- **Report date:** 2021-03-10
- **Termination date:** 2021-08-26

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Parsippany, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0297-2021

## Citation

> AI Analytics. FDA recall D-0297-2021. Retrieved 2026-07-26 from https://api.ai-analytics.org/recall/D-0297-2021. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*